資料載入中.....
|
請使用永久網址來引用或連結此文件:
https://ir.cnu.edu.tw/handle/310902800/27881
|
| 標題: | Lercanidipine and labedipinedilol-A attenuate lipopolysaccharide/interferon-gamma-induced inflammation in rat vascular smooth muscle cells through inhibition of HMGB1 release and MMP-2, 9 activities |
| 作者: | Yeh, Jwu-Lai
Hsu, Jong-Hau
Liang, Jyh-Chong
Chen, Ing-Jun
Liou, Shu-Fen |
| 貢獻者: | 藥學系 |
| 關鍵字: | Dihydropyridine Calcium Channel Blockers
Vascular Smooth Muscle Cells
Lipopolysaccharide/Interferon-Gamma |
| 日期: | 2013-02 |
| 上傳時間: | 2014-05-26 10:47:28 (UTC+8) |
| 出版者: | Elsevier Ireland Ltd |
| 摘要: | Objective: Inflammation is an important molecular basis of atherosclerosis. Recent studies have shown that dihydropyridine calcium channel blockers (CCBs) can exert potent anti-inflammatory effects in models of vascular dysfunction. The purpose of the present study was to evaluate anti-inflammatory effects and mechanisms of lercanidipine and labedipinedilol-A, new generation dihydropyridine CCBs, in rat vascular smooth muscle cells (VSMCs) exposed to lipopolysaccharide (LPS) and interferon-gamma (IFN-gamma).Methods and results: MTT, Griess reagent, RT-PCR, ELISA, gelatin zymography, immunocytochemistry and Western blotting were employed. We found that lercanidipine and labedipinedilol-A attenuated production of NO, ROS and TNF-alpha from LPS/IFN-gamma-stimulated VSMCs. In addition, they both diminished the LPS/IFN-gamma-induced expression of iNOS protein and mRNA, with attenuation of HMGB1 cytosolic translocation and subsequent extracellular release. Furthermore, they down-regulated MMP-2/MMP-9 activities, whereas expression of tissue inhibitor of matrix metalloproteinase-1 (TIMP-1), an inhibitor of MMP-9, was up-regulated. Finally, we found that lercanidipine and labedipinedilol-A inhibited the nuclear translocation of NF-kappa B and suppressed the phosphorylation of JNK, p38 MAPK and Akt.Conclusion: Lercanidipine and labedipinedilol-A can exert their anti-inflammatory effects through suppression of NO, ROS and TNF-alpha through down-regulation of iNOS, MMP-2/MMP-9, and HMGB1, with inhibition of signaling transduction of MAPKs, Akt/IkB-alpha and NF-kappa B pathways. These findings implicate a valuable role of new generation dihydropyridine CCBs lercanidipine and labedipinedilol-A for the treatment of inflammatory vascular diseases. (C) 2012 Elsevier Ireland Ltd. All rights reserved. |
| 關聯: | Atherosclerosis, v.226 n.2, pp.364-372 |
| 顯示於類別: | [藥學系(所)] 期刊論文
|
文件中的檔案:
| 檔案 |
描述 |
大小 | 格式 | 瀏覽次數 |
|---|
| index.html | | 0Kb | HTML | 1501 | 檢視/開啟 |
|
在CNU IR中所有的資料項目都受到原著作權保護.
|
